obesity - 2/15 - Xconomy

Entry	Author	Date	Location
San Diego’s Fight Against Diabesity: The Photo Gallery	Luke Timmerman	01/28/11	San Diego
Arena Pharmaceuticals Axes One-Fourth of Workforce As it Hangs On With Obesity Drug	Luke Timmerman	01/27/11	San Diego
Novartis Acquires Genoptix, Elcelyx Raises $6M, Pfenex Gets Subcontract to Work on Malaria Treatment, & More San Diego Life Sciences News	Bruce V. Bigelow	01/27/11	San Diego
See You Tonight at “San Diego’s Fight Against Diabesity”	Luke Timmerman	01/27/11	San Diego
Stealthy Elcelyx Therapeutics, Focused on Diabetes, Raises $6M	Bruce V. Bigelow	01/26/11	San Diego
Vivus Faces New Safety Issue	Luke Timmerman	01/21/11	San Francisco
J&J Subsidiary Backs Alzheimer Drug Discovery at Sanford-Burnham, Portable Genomics to Move to San Diego, Ardea Plans Secondary Stock Offering, & More San Diego Life Sciences News	Bruce V. Bigelow	01/20/11	San Diego
Sanford-Burnham, Receptos Join “San Diego’s Fight Against Diabesity” on Jan. 27	Luke Timmerman	01/19/11	San Diego
San Diego’s Quest to Fight the “Diabesity” Epidemic, Coming Jan. 27	Luke Timmerman	01/13/11	San Diego
Longwood Raises First Fund, Biogen Adds Executives, Boston Scientific Acquires Intellect, & More Boston-Area Life Sciences News	Erin Kutz	01/07/11	Boston
Zafgen Weight Loss Drug Shows Promise in First Human Test	Luke Timmerman	01/05/11	Boston
How Can San Diego Win the Fight Against Diabesity? Xconomy to Dig Deep on Jan. 27	Luke Timmerman	12/27/10	San Diego
Editor’s Picks: Xconomy Boston’s Top 20 Stories of 2010	Gregory T. Huang	12/27/10	Boston
Navy’s Goal Could Improve Economics of Biofuel Development, Arena Plans More Studies of Weight-Loss Drug, Lpath Signs Deal With Pfizer for Eye Drug, & More San Diego Life Sciences News	Bruce V. Bigelow	12/23/10	San Diego
Vivus Submits Document to FDA	Luke Timmerman	12/14/10	San Francisco
FDA Panel Recommends Orexigen’s Obesity Drug, Sequenom Raises Capital, CommNexus Reorganizes Its Free Incubator, & More San Diego Life Sciences News	Bruce V. Bigelow	12/09/10	San Diego
Orexigen Beats the Odds, Wins OK from FDA Panel for Obesity Drug	Luke Timmerman	12/07/10	San Diego
San Diego’s Fight Against Diabesity: Can Investors Make Money, and Can Startups Still Thrive?	Luke Timmerman	12/03/10	San Diego
The Fight Against Diabesity: How Will San Diego Adapt in the Era of Tough FDA Scrutiny?	Luke Timmerman	11/22/10	San Diego
Ambit Files for IPO, Arena Pharmaceuticals Says Weight-Loss Drug on Track, ESRI Launches Medical Place History Map App, & More San Diego Life Sciences News	Bruce V. Bigelow	11/12/10	San Diego
Arena Reloads for Round 2 with FDA, With More Data on Weight Loss Drug in Diabetes Patients	Luke Timmerman	11/09/10	San Diego
Hyperion Nails Pivotal Trial, ChemoCentryx Aims High Against Crohn’s, Vivus Shot Down by FDA, & More Bay Area Life Sciences News	Luke Timmerman	11/05/10	San Francisco
Biogen Announces Restructuring, FDA Approves Sunovion Drug, Acceleron Cuts Workforce, & More Boston-Area Life Sciences News	Erin Kutz	11/05/10	Boston
Ideo Spinoff ShopWell Says Better Health Starts at the Supermarket; Part 3: Food as Data	Wade Roush	11/03/10	San Francisco
Energesis Pharmaceuticals, Co-Founded by Sirtris Vet, Seeks to Tap Power of “Good Fat” in Fighting Obesity and Diabetes	Ryan McBride	11/03/10	Boston
Ideo Spinoff ShopWell Says Better Health Starts at the Supermarket; Part 2: Ingredients of a Startup	Wade Roush	11/02/10	San Francisco
ShopWell, Ideo’s First Big Spinoff, Says Better Health Starts at the Supermarket	Wade Roush	11/01/10	San Francisco
Vivus Turned Down by FDA	Luke Timmerman	10/29/10	San Francisco
Life Technologies’ CEO Talks Strategy, Phenomix Falls, Arena Pharmaceuticals Grapples With FDA Setback, & More San Diego Life Sciences News	Bruce V. Bigelow	10/28/10	San Diego
Arena Obesity Drug Fails to Win FDA Approval, May Need More Clinical Testing	Luke Timmerman	10/25/10	San Diego
Page 2 of 5	« previous page · next page »

Entry

Author

Date

Location

San Diego’s Fight Against Diabesity: The Photo Gallery

Luke Timmerman

01/28/11

San Diego

Arena Pharmaceuticals Axes One-Fourth of Workforce As it Hangs On With Obesity Drug

Luke Timmerman

01/27/11

San Diego